Serveur d'exploration sur la maladie de Parkinson

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Cognitive correlates of visual hallucinations in dementia associated with Parkinson's disease

Identifieur interne : 002B10 ( Main/Corpus ); précédent : 002B09; suivant : 002B11

Cognitive correlates of visual hallucinations in dementia associated with Parkinson's disease

Auteurs : Kolbjorn Bronnick ; Murat Emre ; Sibel Tekin ; Siri B. Haugen ; Dag Aarsland

Source :

RBID : ISTEX:9B4059B09B7B00F11F2DF1CFD212DAB01789C6B3

English descriptors

Abstract

Background:: There may be a relationship between cognitive impairment and visual hallucinations (VHs) in patients with Parkinson's disease (PD). The objective of this study was to compare the cognitive profile of hallucinating vs. nonhallucinating patients with Parkinson's disease dementia (PDD). Methods:: The cognitive profile of 86 PDD patients with hallucinations was compared with that of a carefully matched PDD group without hallucinations, all drawn from the baseline assessments of the EXPRESS study with rivastigmine. Logistic regression analysis was employed to identify cognitive measures that have an independent relationship with presence of hallucinations. Results:: Worse choice reaction time was the only independent predictor of hallucinations in the logistic regression. A further analysis of the reaction time tasks showed that response selection deficit as opposed to stimulus discrimination deficit was the main difference between the groups. Discussion:: These results indicate that attentional control is an important cognitive correlate of VHs in patients with PDD. © 2011 Movement Disorder Society

Url:
DOI: 10.1002/mds.23525

Links to Exploration step

ISTEX:9B4059B09B7B00F11F2DF1CFD212DAB01789C6B3

Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Cognitive correlates of visual hallucinations in dementia associated with Parkinson's disease</title>
<author>
<name sortKey="Bronnick, Kolbjorn" sort="Bronnick, Kolbjorn" uniqKey="Bronnick K" first="Kolbjorn" last="Bronnick">Kolbjorn Bronnick</name>
<affiliation>
<mods:affiliation>Norwegian centre for movement disorders, Stavanger University Hospital, Helse Stavanger, Norway</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Emre, Murat" sort="Emre, Murat" uniqKey="Emre M" first="Murat" last="Emre">Murat Emre</name>
<affiliation>
<mods:affiliation>Department of Neurology, Istanbul Faculty of Medicine, Istanbul University, Turkey</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Tekin, Sibel" sort="Tekin, Sibel" uniqKey="Tekin S" first="Sibel" last="Tekin">Sibel Tekin</name>
<affiliation>
<mods:affiliation>Novartis Pharmaceuticals, East Hanover, New Jersey, USA</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Haugen, Siri B" sort="Haugen, Siri B" uniqKey="Haugen S" first="Siri B." last="Haugen">Siri B. Haugen</name>
<affiliation>
<mods:affiliation>Department for Treatment of Addictive Behaviours, Akershus University Hospital Trust, Norway</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Aarsland, Dag" sort="Aarsland, Dag" uniqKey="Aarsland D" first="Dag" last="Aarsland">Dag Aarsland</name>
<affiliation>
<mods:affiliation>Department of old age psychiatry, Psychiatric Clinic, Stavanger University Hospital, Stavanger, Norway</mods:affiliation>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:9B4059B09B7B00F11F2DF1CFD212DAB01789C6B3</idno>
<date when="2011" year="2011">2011</date>
<idno type="doi">10.1002/mds.23525</idno>
<idno type="url">https://api.istex.fr/document/9B4059B09B7B00F11F2DF1CFD212DAB01789C6B3/fulltext/pdf</idno>
<idno type="wicri:Area/Main/Corpus">002B10</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a" type="main" xml:lang="en">Cognitive correlates of visual hallucinations in dementia associated with Parkinson's disease</title>
<author>
<name sortKey="Bronnick, Kolbjorn" sort="Bronnick, Kolbjorn" uniqKey="Bronnick K" first="Kolbjorn" last="Bronnick">Kolbjorn Bronnick</name>
<affiliation>
<mods:affiliation>Norwegian centre for movement disorders, Stavanger University Hospital, Helse Stavanger, Norway</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Emre, Murat" sort="Emre, Murat" uniqKey="Emre M" first="Murat" last="Emre">Murat Emre</name>
<affiliation>
<mods:affiliation>Department of Neurology, Istanbul Faculty of Medicine, Istanbul University, Turkey</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Tekin, Sibel" sort="Tekin, Sibel" uniqKey="Tekin S" first="Sibel" last="Tekin">Sibel Tekin</name>
<affiliation>
<mods:affiliation>Novartis Pharmaceuticals, East Hanover, New Jersey, USA</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Haugen, Siri B" sort="Haugen, Siri B" uniqKey="Haugen S" first="Siri B." last="Haugen">Siri B. Haugen</name>
<affiliation>
<mods:affiliation>Department for Treatment of Addictive Behaviours, Akershus University Hospital Trust, Norway</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Aarsland, Dag" sort="Aarsland, Dag" uniqKey="Aarsland D" first="Dag" last="Aarsland">Dag Aarsland</name>
<affiliation>
<mods:affiliation>Department of old age psychiatry, Psychiatric Clinic, Stavanger University Hospital, Stavanger, Norway</mods:affiliation>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j">Movement Disorders</title>
<title level="j" type="abbrev">Mov. Disord.</title>
<idno type="ISSN">0885-3185</idno>
<idno type="eISSN">1531-8257</idno>
<imprint>
<publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>Hoboken</pubPlace>
<date type="published" when="2011-04">2011-04</date>
<biblScope unit="volume">26</biblScope>
<biblScope unit="issue">5</biblScope>
<biblScope unit="page" from="824">824</biblScope>
<biblScope unit="page" to="829">829</biblScope>
</imprint>
<idno type="ISSN">0885-3185</idno>
</series>
<idno type="istex">9B4059B09B7B00F11F2DF1CFD212DAB01789C6B3</idno>
<idno type="DOI">10.1002/mds.23525</idno>
<idno type="ArticleID">MDS23525</idno>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Parkinson's disease</term>
<term>attention</term>
<term>cognition</term>
<term>dementia</term>
<term>visual hallucinations</term>
</keywords>
</textClass>
<langUsage>
<language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Background:: There may be a relationship between cognitive impairment and visual hallucinations (VHs) in patients with Parkinson's disease (PD). The objective of this study was to compare the cognitive profile of hallucinating vs. nonhallucinating patients with Parkinson's disease dementia (PDD). Methods:: The cognitive profile of 86 PDD patients with hallucinations was compared with that of a carefully matched PDD group without hallucinations, all drawn from the baseline assessments of the EXPRESS study with rivastigmine. Logistic regression analysis was employed to identify cognitive measures that have an independent relationship with presence of hallucinations. Results:: Worse choice reaction time was the only independent predictor of hallucinations in the logistic regression. A further analysis of the reaction time tasks showed that response selection deficit as opposed to stimulus discrimination deficit was the main difference between the groups. Discussion:: These results indicate that attentional control is an important cognitive correlate of VHs in patients with PDD. © 2011 Movement Disorder Society</div>
</front>
</TEI>
<istex>
<corpusName>wiley</corpusName>
<author>
<json:item>
<name>Kolbjorn Bronnick PhD, MSc</name>
<affiliations>
<json:string>Norwegian centre for movement disorders, Stavanger University Hospital, Helse Stavanger, Norway</json:string>
</affiliations>
</json:item>
<json:item>
<name>Murat Emre MD</name>
<affiliations>
<json:string>Department of Neurology, Istanbul Faculty of Medicine, Istanbul University, Turkey</json:string>
</affiliations>
</json:item>
<json:item>
<name>Sibel Tekin MD</name>
<affiliations>
<json:string>Novartis Pharmaceuticals, East Hanover, New Jersey, USA</json:string>
</affiliations>
</json:item>
<json:item>
<name>Siri B. Haugen MSc</name>
<affiliations>
<json:string>Department for Treatment of Addictive Behaviours, Akershus University Hospital Trust, Norway</json:string>
</affiliations>
</json:item>
<json:item>
<name>Dag Aarsland MD, PhD</name>
<affiliations>
<json:string>Department of old age psychiatry, Psychiatric Clinic, Stavanger University Hospital, Stavanger, Norway</json:string>
</affiliations>
</json:item>
</author>
<subject>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>Parkinson's disease</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>visual hallucinations</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>cognition</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>dementia</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>attention</value>
</json:item>
</subject>
<articleId>
<json:string>MDS23525</json:string>
</articleId>
<language>
<json:string>eng</json:string>
</language>
<abstract>Background:: There may be a relationship between cognitive impairment and visual hallucinations (VHs) in patients with Parkinson's disease (PD). The objective of this study was to compare the cognitive profile of hallucinating vs. nonhallucinating patients with Parkinson's disease dementia (PDD). Methods:: The cognitive profile of 86 PDD patients with hallucinations was compared with that of a carefully matched PDD group without hallucinations, all drawn from the baseline assessments of the EXPRESS study with rivastigmine. Logistic regression analysis was employed to identify cognitive measures that have an independent relationship with presence of hallucinations. Results:: Worse choice reaction time was the only independent predictor of hallucinations in the logistic regression. A further analysis of the reaction time tasks showed that response selection deficit as opposed to stimulus discrimination deficit was the main difference between the groups. Discussion:: These results indicate that attentional control is an important cognitive correlate of VHs in patients with PDD. © 2011 Movement Disorder Society</abstract>
<qualityIndicators>
<score>5.543</score>
<pdfVersion>1.3</pdfVersion>
<pdfPageSize>612 x 810 pts</pdfPageSize>
<refBibsNative>true</refBibsNative>
<keywordCount>5</keywordCount>
<abstractCharCount>1124</abstractCharCount>
<pdfWordCount>3659</pdfWordCount>
<pdfCharCount>25081</pdfCharCount>
<pdfPageCount>6</pdfPageCount>
<abstractWordCount>157</abstractWordCount>
</qualityIndicators>
<title>Cognitive correlates of visual hallucinations in dementia associated with Parkinson's disease</title>
<genre>
<json:string>article</json:string>
</genre>
<host>
<volume>26</volume>
<publisherId>
<json:string>MDS</json:string>
</publisherId>
<pages>
<total>6</total>
<last>829</last>
<first>824</first>
</pages>
<issn>
<json:string>0885-3185</json:string>
</issn>
<issue>5</issue>
<subject>
<json:item>
<value>Research Article</value>
</json:item>
</subject>
<genre>
<json:string>Journal</json:string>
</genre>
<language>
<json:string>unknown</json:string>
</language>
<eissn>
<json:string>1531-8257</json:string>
</eissn>
<title>Movement Disorders</title>
<doi>
<json:string>10.1002/(ISSN)1531-8257</json:string>
</doi>
</host>
<publicationDate>2011</publicationDate>
<copyrightDate>2011</copyrightDate>
<doi>
<json:string>10.1002/mds.23525</json:string>
</doi>
<id>9B4059B09B7B00F11F2DF1CFD212DAB01789C6B3</id>
<fulltext>
<json:item>
<original>true</original>
<mimetype>application/pdf</mimetype>
<extension>pdf</extension>
<uri>https://api.istex.fr/document/9B4059B09B7B00F11F2DF1CFD212DAB01789C6B3/fulltext/pdf</uri>
</json:item>
<json:item>
<original>false</original>
<mimetype>application/zip</mimetype>
<extension>zip</extension>
<uri>https://api.istex.fr/document/9B4059B09B7B00F11F2DF1CFD212DAB01789C6B3/fulltext/zip</uri>
</json:item>
<istex:fulltextTEI uri="https://api.istex.fr/document/9B4059B09B7B00F11F2DF1CFD212DAB01789C6B3/fulltext/tei">
<teiHeader>
<fileDesc>
<titleStmt>
<title level="a" type="main" xml:lang="en">Cognitive correlates of visual hallucinations in dementia associated with Parkinson's disease</title>
</titleStmt>
<publicationStmt>
<authority>ISTEX</authority>
<publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>Hoboken</pubPlace>
<availability>
<p>WILEY</p>
</availability>
<date>2011</date>
</publicationStmt>
<notesStmt>
<note type="content">*Relevant conflict of interest/financial disclosures: Nothing to report. Full financial disclosures and author roles may be found in the online version of this article.</note>
</notesStmt>
<sourceDesc>
<biblStruct type="inbook">
<analytic>
<title level="a" type="main" xml:lang="en">Cognitive correlates of visual hallucinations in dementia associated with Parkinson's disease</title>
<author>
<persName>
<forename type="first">Kolbjorn</forename>
<surname>Bronnick</surname>
</persName>
<roleName type="degree">PhD, MSc</roleName>
<note type="correspondence">
<p>Correspondence: Norwegian centre for movement disorders, Stavanger University Hospital, Norway. Pbox 8100, 4068 Stavanger, Norway</p>
</note>
<affiliation>Norwegian centre for movement disorders, Stavanger University Hospital, Helse Stavanger, Norway</affiliation>
</author>
<author>
<persName>
<forename type="first">Murat</forename>
<surname>Emre</surname>
</persName>
<roleName type="degree">MD</roleName>
<affiliation>Department of Neurology, Istanbul Faculty of Medicine, Istanbul University, Turkey</affiliation>
</author>
<author>
<persName>
<forename type="first">Sibel</forename>
<surname>Tekin</surname>
</persName>
<roleName type="degree">MD</roleName>
<affiliation>Novartis Pharmaceuticals, East Hanover, New Jersey, USA</affiliation>
</author>
<author>
<persName>
<forename type="first">Siri B.</forename>
<surname>Haugen</surname>
</persName>
<roleName type="degree">MSc</roleName>
<affiliation>Department for Treatment of Addictive Behaviours, Akershus University Hospital Trust, Norway</affiliation>
</author>
<author>
<persName>
<forename type="first">Dag</forename>
<surname>Aarsland</surname>
</persName>
<roleName type="degree">MD, PhD</roleName>
<affiliation>Department of old age psychiatry, Psychiatric Clinic, Stavanger University Hospital, Stavanger, Norway</affiliation>
</author>
</analytic>
<monogr>
<title level="j">Movement Disorders</title>
<title level="j" type="abbrev">Mov. Disord.</title>
<idno type="pISSN">0885-3185</idno>
<idno type="eISSN">1531-8257</idno>
<idno type="DOI">10.1002/(ISSN)1531-8257</idno>
<imprint>
<publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>Hoboken</pubPlace>
<date type="published" when="2011-04"></date>
<biblScope unit="volume">26</biblScope>
<biblScope unit="issue">5</biblScope>
<biblScope unit="page" from="824">824</biblScope>
<biblScope unit="page" to="829">829</biblScope>
</imprint>
</monogr>
<idno type="istex">9B4059B09B7B00F11F2DF1CFD212DAB01789C6B3</idno>
<idno type="DOI">10.1002/mds.23525</idno>
<idno type="ArticleID">MDS23525</idno>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<creation>
<date>2011</date>
</creation>
<langUsage>
<language ident="en">en</language>
</langUsage>
<abstract xml:lang="en">
<p>Background:: There may be a relationship between cognitive impairment and visual hallucinations (VHs) in patients with Parkinson's disease (PD). The objective of this study was to compare the cognitive profile of hallucinating vs. nonhallucinating patients with Parkinson's disease dementia (PDD). Methods:: The cognitive profile of 86 PDD patients with hallucinations was compared with that of a carefully matched PDD group without hallucinations, all drawn from the baseline assessments of the EXPRESS study with rivastigmine. Logistic regression analysis was employed to identify cognitive measures that have an independent relationship with presence of hallucinations. Results:: Worse choice reaction time was the only independent predictor of hallucinations in the logistic regression. A further analysis of the reaction time tasks showed that response selection deficit as opposed to stimulus discrimination deficit was the main difference between the groups. Discussion:: These results indicate that attentional control is an important cognitive correlate of VHs in patients with PDD. © 2011 Movement Disorder Society</p>
</abstract>
<textClass xml:lang="en">
<keywords scheme="keyword">
<list>
<head>Keywords</head>
<item>
<term>Parkinson's disease</term>
</item>
<item>
<term>visual hallucinations</term>
</item>
<item>
<term>cognition</term>
</item>
<item>
<term>dementia</term>
</item>
<item>
<term>attention</term>
</item>
</list>
</keywords>
</textClass>
<textClass>
<keywords scheme="Journal Subject">
<list>
<head>article category</head>
<item>
<term>Research Article</term>
</item>
</list>
</keywords>
</textClass>
</profileDesc>
<revisionDesc>
<change when="2010-03-02">Received</change>
<change when="2010-10-18">Registration</change>
<change when="2011-04">Published</change>
</revisionDesc>
</teiHeader>
</istex:fulltextTEI>
<json:item>
<original>false</original>
<mimetype>text/plain</mimetype>
<extension>txt</extension>
<uri>https://api.istex.fr/document/9B4059B09B7B00F11F2DF1CFD212DAB01789C6B3/fulltext/txt</uri>
</json:item>
</fulltext>
<metadata>
<istex:metadataXml wicri:clean="Wiley, elements deleted: body">
<istex:xmlDeclaration>version="1.0" encoding="UTF-8" standalone="yes"</istex:xmlDeclaration>
<istex:document>
<component version="2.0" type="serialArticle" xml:lang="en">
<header>
<publicationMeta level="product">
<publisherInfo>
<publisherName>Wiley Subscription Services, Inc., A Wiley Company</publisherName>
<publisherLoc>Hoboken</publisherLoc>
</publisherInfo>
<doi registered="yes">10.1002/(ISSN)1531-8257</doi>
<issn type="print">0885-3185</issn>
<issn type="electronic">1531-8257</issn>
<idGroup>
<id type="product" value="MDS"></id>
</idGroup>
<titleGroup>
<title type="main" xml:lang="en" sort="MOVEMENT DISORDERS">Movement Disorders</title>
<title type="short">Mov. Disord.</title>
</titleGroup>
</publicationMeta>
<publicationMeta level="part" position="50">
<doi origin="wiley" registered="yes">10.1002/mds.v26.5</doi>
<numberingGroup>
<numbering type="journalVolume" number="26">26</numbering>
<numbering type="journalIssue">5</numbering>
</numberingGroup>
<coverDate startDate="2011-04">April 2011</coverDate>
</publicationMeta>
<publicationMeta level="unit" type="article" position="120" status="forIssue">
<doi origin="wiley" registered="yes">10.1002/mds.23525</doi>
<idGroup>
<id type="unit" value="MDS23525"></id>
</idGroup>
<countGroup>
<count type="pageTotal" number="6"></count>
</countGroup>
<titleGroup>
<title type="articleCategory">Research Article</title>
<title type="tocHeading1">Research Articles</title>
</titleGroup>
<copyright ownership="thirdParty">Copyright © 2011 Movement Disorder Society</copyright>
<eventGroup>
<event type="manuscriptReceived" date="2010-03-02"></event>
<event type="manuscriptRevised" date="2010-09-24"></event>
<event type="manuscriptAccepted" date="2010-10-18"></event>
<event type="xmlConverted" agent="Converter:JWSART34_TO_WML3G version:2.5.2 mode:FullText" date="2011-07-19"></event>
<event type="publishedOnlineEarlyUnpaginated" date="2011-03-21"></event>
<event type="publishedOnlineFinalForm" date="2011-04-21"></event>
<event type="firstOnline" date="2011-03-21"></event>
<event type="xmlConverted" agent="Converter:WILEY_ML3G_TO_WILEY_ML3GV2 version:3.8.8" date="2014-02-02"></event>
<event type="xmlConverted" agent="Converter:WML3G_To_WML3G version:4.1.7 mode:FullText,remove_FC" date="2014-10-31"></event>
</eventGroup>
<numberingGroup>
<numbering type="pageFirst">824</numbering>
<numbering type="pageLast">829</numbering>
</numberingGroup>
<correspondenceTo>Norwegian centre for movement disorders, Stavanger University Hospital, Norway. Pbox 8100, 4068 Stavanger, Norway</correspondenceTo>
<linkGroup>
<link type="toTypesetVersion" href="file:MDS.MDS23525.pdf"></link>
</linkGroup>
</publicationMeta>
<contentMeta>
<countGroup>
<count type="figureTotal" number="0"></count>
<count type="tableTotal" number="3"></count>
<count type="referenceTotal" number="36"></count>
<count type="wordTotal" number="5339"></count>
</countGroup>
<titleGroup>
<title type="main" xml:lang="en">Cognitive correlates of visual hallucinations in dementia associated with Parkinson's disease
<link href="#fn3"></link>
</title>
<title type="short" xml:lang="en">Cognitive Correlates of Visual Hallucinations</title>
</titleGroup>
<creators>
<creator xml:id="au1" creatorRole="author" affiliationRef="#af1" corresponding="yes">
<personName>
<givenNames>Kolbjorn</givenNames>
<familyName>Bronnick</familyName>
<degrees>PhD, MSc</degrees>
</personName>
<contactDetails>
<email>bronnick@gmail.com</email>
</contactDetails>
</creator>
<creator xml:id="au2" creatorRole="author" affiliationRef="#af2">
<personName>
<givenNames>Murat</givenNames>
<familyName>Emre</familyName>
<degrees>MD</degrees>
</personName>
</creator>
<creator xml:id="au3" creatorRole="author" affiliationRef="#af3">
<personName>
<givenNames>Sibel</givenNames>
<familyName>Tekin</familyName>
<degrees>MD</degrees>
</personName>
</creator>
<creator xml:id="au4" creatorRole="author" affiliationRef="#af4">
<personName>
<givenNames>Siri B.</givenNames>
<familyName>Haugen</familyName>
<degrees>MSc</degrees>
</personName>
</creator>
<creator xml:id="au5" creatorRole="author" affiliationRef="#af5">
<personName>
<givenNames>Dag</givenNames>
<familyName>Aarsland</familyName>
<degrees>MD, PhD</degrees>
</personName>
</creator>
</creators>
<affiliationGroup>
<affiliation xml:id="af1" countryCode="NO" type="organization">
<unparsedAffiliation>Norwegian centre for movement disorders, Stavanger University Hospital, Helse Stavanger, Norway</unparsedAffiliation>
</affiliation>
<affiliation xml:id="af2" countryCode="TR" type="organization">
<unparsedAffiliation>Department of Neurology, Istanbul Faculty of Medicine, Istanbul University, Turkey</unparsedAffiliation>
</affiliation>
<affiliation xml:id="af3" countryCode="US" type="organization">
<unparsedAffiliation>Novartis Pharmaceuticals, East Hanover, New Jersey, USA</unparsedAffiliation>
</affiliation>
<affiliation xml:id="af4" countryCode="NO" type="organization">
<unparsedAffiliation>Department for Treatment of Addictive Behaviours, Akershus University Hospital Trust, Norway</unparsedAffiliation>
</affiliation>
<affiliation xml:id="af5" countryCode="NO" type="organization">
<unparsedAffiliation>Department of old age psychiatry, Psychiatric Clinic, Stavanger University Hospital, Stavanger, Norway</unparsedAffiliation>
</affiliation>
</affiliationGroup>
<keywordGroup xml:lang="en" type="author">
<keyword xml:id="kwd1">Parkinson's disease</keyword>
<keyword xml:id="kwd2">visual hallucinations</keyword>
<keyword xml:id="kwd3">cognition</keyword>
<keyword xml:id="kwd4">dementia</keyword>
<keyword xml:id="kwd5">attention</keyword>
</keywordGroup>
<abstractGroup>
<abstract type="main" xml:lang="en">
<title type="main">Abstract</title>
<section xml:id="abs1-1">
<title type="main">Background:</title>
<p>There may be a relationship between cognitive impairment and visual hallucinations (VHs) in patients with Parkinson's disease (PD). The objective of this study was to compare the cognitive profile of hallucinating vs. nonhallucinating patients with Parkinson's disease dementia (PDD).</p>
</section>
<section xml:id="abs1-2">
<title type="main">Methods:</title>
<p>The cognitive profile of 86 PDD patients with hallucinations was compared with that of a carefully matched PDD group without hallucinations, all drawn from the baseline assessments of the EXPRESS study with rivastigmine. Logistic regression analysis was employed to identify cognitive measures that have an independent relationship with presence of hallucinations.</p>
</section>
<section xml:id="abs1-3">
<title type="main">Results:</title>
<p>Worse choice reaction time was the only independent predictor of hallucinations in the logistic regression. A further analysis of the reaction time tasks showed that response selection deficit as opposed to stimulus discrimination deficit was the main difference between the groups.</p>
</section>
<section xml:id="abs1-4">
<title type="main">Discussion:</title>
<p>These results indicate that attentional control is an important cognitive correlate of VHs in patients with PDD. © 2011 Movement Disorder Society</p>
</section>
</abstract>
</abstractGroup>
</contentMeta>
<noteGroup>
<note xml:id="fn3">
<p>
<b>Relevant conflict of interest/financial disclosures:</b>
Nothing to report.</p>
<p>Full financial disclosures and author roles may be found in the online version of this article.</p>
</note>
</noteGroup>
</header>
</component>
</istex:document>
</istex:metadataXml>
<mods version="3.6">
<titleInfo lang="en">
<title>Cognitive correlates of visual hallucinations in dementia associated with Parkinson's disease</title>
</titleInfo>
<titleInfo type="abbreviated" lang="en">
<title>Cognitive Correlates of Visual Hallucinations</title>
</titleInfo>
<titleInfo type="alternative" contentType="CDATA" lang="en">
<title>Cognitive correlates of visual hallucinations in dementia associated with Parkinson's disease</title>
</titleInfo>
<name type="personal">
<namePart type="given">Kolbjorn</namePart>
<namePart type="family">Bronnick</namePart>
<namePart type="termsOfAddress">PhD, MSc</namePart>
<affiliation>Norwegian centre for movement disorders, Stavanger University Hospital, Helse Stavanger, Norway</affiliation>
<description>Correspondence: Norwegian centre for movement disorders, Stavanger University Hospital, Norway. Pbox 8100, 4068 Stavanger, Norway</description>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">Murat</namePart>
<namePart type="family">Emre</namePart>
<namePart type="termsOfAddress">MD</namePart>
<affiliation>Department of Neurology, Istanbul Faculty of Medicine, Istanbul University, Turkey</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">Sibel</namePart>
<namePart type="family">Tekin</namePart>
<namePart type="termsOfAddress">MD</namePart>
<affiliation>Novartis Pharmaceuticals, East Hanover, New Jersey, USA</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">Siri B.</namePart>
<namePart type="family">Haugen</namePart>
<namePart type="termsOfAddress">MSc</namePart>
<affiliation>Department for Treatment of Addictive Behaviours, Akershus University Hospital Trust, Norway</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">Dag</namePart>
<namePart type="family">Aarsland</namePart>
<namePart type="termsOfAddress">MD, PhD</namePart>
<affiliation>Department of old age psychiatry, Psychiatric Clinic, Stavanger University Hospital, Stavanger, Norway</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<typeOfResource>text</typeOfResource>
<genre type="article" displayLabel="article"></genre>
<originInfo>
<publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<place>
<placeTerm type="text">Hoboken</placeTerm>
</place>
<dateIssued encoding="w3cdtf">2011-04</dateIssued>
<dateCaptured encoding="w3cdtf">2010-03-02</dateCaptured>
<dateValid encoding="w3cdtf">2010-10-18</dateValid>
<copyrightDate encoding="w3cdtf">2011</copyrightDate>
</originInfo>
<language>
<languageTerm type="code" authority="rfc3066">en</languageTerm>
<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
</language>
<physicalDescription>
<internetMediaType>text/html</internetMediaType>
<extent unit="tables">3</extent>
<extent unit="references">36</extent>
<extent unit="words">5339</extent>
</physicalDescription>
<abstract lang="en">Background:: There may be a relationship between cognitive impairment and visual hallucinations (VHs) in patients with Parkinson's disease (PD). The objective of this study was to compare the cognitive profile of hallucinating vs. nonhallucinating patients with Parkinson's disease dementia (PDD). Methods:: The cognitive profile of 86 PDD patients with hallucinations was compared with that of a carefully matched PDD group without hallucinations, all drawn from the baseline assessments of the EXPRESS study with rivastigmine. Logistic regression analysis was employed to identify cognitive measures that have an independent relationship with presence of hallucinations. Results:: Worse choice reaction time was the only independent predictor of hallucinations in the logistic regression. A further analysis of the reaction time tasks showed that response selection deficit as opposed to stimulus discrimination deficit was the main difference between the groups. Discussion:: These results indicate that attentional control is an important cognitive correlate of VHs in patients with PDD. © 2011 Movement Disorder Society</abstract>
<note type="content">*Relevant conflict of interest/financial disclosures: Nothing to report. Full financial disclosures and author roles may be found in the online version of this article.</note>
<subject lang="en">
<genre>Keywords</genre>
<topic>Parkinson's disease</topic>
<topic>visual hallucinations</topic>
<topic>cognition</topic>
<topic>dementia</topic>
<topic>attention</topic>
</subject>
<relatedItem type="host">
<titleInfo>
<title>Movement Disorders</title>
</titleInfo>
<titleInfo type="abbreviated">
<title>Mov. Disord.</title>
</titleInfo>
<genre type="Journal">journal</genre>
<subject>
<genre>article category</genre>
<topic>Research Article</topic>
</subject>
<identifier type="ISSN">0885-3185</identifier>
<identifier type="eISSN">1531-8257</identifier>
<identifier type="DOI">10.1002/(ISSN)1531-8257</identifier>
<identifier type="PublisherID">MDS</identifier>
<part>
<date>2011</date>
<detail type="volume">
<caption>vol.</caption>
<number>26</number>
</detail>
<detail type="issue">
<caption>no.</caption>
<number>5</number>
</detail>
<extent unit="pages">
<start>824</start>
<end>829</end>
<total>6</total>
</extent>
</part>
</relatedItem>
<identifier type="istex">9B4059B09B7B00F11F2DF1CFD212DAB01789C6B3</identifier>
<identifier type="DOI">10.1002/mds.23525</identifier>
<identifier type="ArticleID">MDS23525</identifier>
<accessCondition type="use and reproduction" contentType="copyright">Copyright © 2011 Movement Disorder Society</accessCondition>
<recordInfo>
<recordContentSource>WILEY</recordContentSource>
<recordOrigin>Wiley Subscription Services, Inc., A Wiley Company</recordOrigin>
</recordInfo>
</mods>
</metadata>
<serie></serie>
</istex>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonV1/Data/Main/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002B10 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd -nk 002B10 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonV1
   |flux=    Main
   |étape=   Corpus
   |type=    RBID
   |clé=     ISTEX:9B4059B09B7B00F11F2DF1CFD212DAB01789C6B3
   |texte=   Cognitive correlates of visual hallucinations in dementia associated with Parkinson's disease
}}

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 18:06:51 2016. Site generation: Wed Mar 6 18:46:03 2024